These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3301664)

  • 1. Central dopaminergic regulation of aldosterone secretion in sheep.
    Huang BS; Malvin RL; Lee J; Grekin RJ
    Hypertension; 1987 Aug; 10(2):157-63. PubMed ID: 3301664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral effects of dopamine on the renin-angiotensin-aldosterone system in conscious rats.
    Kondo K; Suzuki H; Handa M; Nagahama S; Yasui T; Fujimaki M; Ogihara T; Saruta T
    Jpn Circ J; 1981 Sep; 45(9):1121-5. PubMed ID: 7029031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of angiotensin II and dopamine in sodium-depleted sheep.
    Huang BS; Malvin RL; Grekin RJ
    Am J Physiol; 1985 May; 248(5 Pt 2):R541-8. PubMed ID: 3887949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the central effects of dopamine and metoclopramide on aldosterone regulation in the rat.
    Kawabe H; Kondo K; Hayashi M; Fujimaki M; Nagahama S; Saruta T
    Endocrinol Jpn; 1983 Aug; 30(4):543-9. PubMed ID: 6323152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of direct effect of dopamine on aldosterone secretion in vivo.
    Lun S; Espiner EA; Nicholls MG; Hart DS
    Endocrinology; 1983 Jan; 112(1):60-3. PubMed ID: 6847834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of some central actions of angiotensin II in vivo.
    Huang BS; Malvin RL
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):405-9. PubMed ID: 3047744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of aldosterone secretion?
    McDougall JG; Scoggins BA; Butkus A; Coghlan JP; Denton DA; Fei DT; Hardy KJ; Wright RD
    J Endocrinol; 1981 Nov; 91(2):271-80. PubMed ID: 7299326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR; Eggena P; Phillips D
    Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine in the regulation of blood pressure and the renin--angiotensin--aldosterone system in conscious rats.
    Kondo K; Ebihara A; Suzuki H; Saruta T
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():235s-237s. PubMed ID: 7032812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metoclopramide and haloperidol on plasma renin activity and aldosterone levels in rats.
    Jungmann E; Wächtler M; Schwedes U; Usadel KH; Schöffling K
    Res Exp Med (Berl); 1983; 183(2):133-8. PubMed ID: 6361937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
    Sowers JR; Berg G; Martin VS; Mayes DM
    Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
    Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
    J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
    Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone-cortisol interaction in control of renin activity but not aldosterone.
    Keller-Wood M; Silbiger J; Wood CE
    Am J Physiol; 1990 Aug; 259(2 Pt 2):R350-6. PubMed ID: 2201219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.